Throughout the last three months, 6 analysts have evaluated Twist Bioscience (NASDAQ:TWST), offering a diverse set of opinions from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 5 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 1 | 0 | 0 | 0 |
| 2M Ago | 0 | 4 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $46.0, a high estimate of $53.00, and a low estimate of $40.00. Marking an increase of 7.98%, the current average surpasses the previous average price target of $42.60.
Exploring Analyst Ratings: An In-Depth Overview
A...
Login or create a forever free account to read this news
Sign up/Log in